Umbilical cord blood transfer in very premature babies
Part of Blood & lymphatic, Genetic & congenital, Women’s health & pregnancy clinical trials.
This trial tests different ways of transferring blood from the umbilical cord to very premature babies (born at or before 32 weeks) to see if it can prevent complications of prematurity and improve their blood counts. It aims to find the best method for helping these vulnerable newborns.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby was born at or before 32 weeks of pregnancy
- Your baby is admitted to the neonatal intensive care unit (NICU) within the first 24 hours of life
- Your baby does not have a major birth defect, like a serious heart problem or a brain abnormality
- Your baby did not have a head injury that caused a large bleed in the brain
- The placenta was not abnormal (e.g., detached early, covering the cervix, or had a blood clot behind it)
- There was no problem with the umbilical cord during delivery (e.g., cord accident or tearing)
- The obstetrician agrees to perform the procedure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using cord blood (the blood left in the umbilical cord after birth) that is rich in fetal hemoglobin (the type of hemoglobin babies have before birth) can make blood transfusions safer and more personalized for very premature babies. If this works, it might reduce the need for multiple transfusions and improve outcomes for preterm infants.
This study tests whether gently squeezing the umbilical cord before clamping it (called cord milking) helps premature babies who are not vigorous at birth. It is being done in hospitals with fewer resources to find safe and effective ways to improve oxygen and blood flow right after delivery.
This study tests whether red blood cells made from donated cord blood are safe and effective for very premature babies who need a transfusion. It may offer an alternative to standard donor blood for these fragile infants.
This study compares two different amounts of platelet transfusions to see which is safer and more effective for premature babies with very low platelet counts. Platelets are tiny cells in the blood that help stop bleeding, so this treatment may reduce the risk of serious bleeding in the brain.
This study looks at the best way to decide when to give platelet transfusions to very premature babies. It aims to help prevent bleeding while avoiding unnecessary transfusions.
This trial looks at whether it’s safer to temporarily withhold (pause) breast milk or formula feeds around the time of a blood transfusion in very premature babies. It may help reduce gut-related complications like NEC, a serious intestinal problem.
Hear when a new Premature trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.